Studies have shown that localized skin inflammation in cutaneous leishmaniasis leads to a chronic systemic IFN-γ signature, with increased expression of cytotoxic markers GZMB, Pore-forming protein 1(PRF1), and GNLY. The gene discussed is GZMB; the disease is cutaneous leishmaniasis.